INKT - Financial Reports List - MiNK Therapeutics, Inc. - IntrinsicAlpha

MiNK Therapeutics, Inc. INKT

Healthcare - Biotechnology - NASDAQ - US

$ 7.4

6.8 %

$ 29.5 M

Market Cap

-2.69

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-72453.97%	100.00%
Quarterly Report	Q4	8-K	2024-12-31	100.00%	54.88%	54.50%
Annual Report	FY	10-K	2024-12-31	0.00%	51.98%	53.54%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	64.69%	63.92%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	56.40%	51.59%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-2.35%	34.58%
Quarterly Report	Q4	8-K	2023-12-31	-432.88%	27.12%	30.28%
Annual Report	FY	10-K	2023-12-31	0.00%	9.37%	25.94%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-11.64%	34.60%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-37.69%	17.60%

1